Page last updated: 2024-09-04

levofloxacin and Staphylococcal Skin Infections

levofloxacin has been researched along with Staphylococcal Skin Infections in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD1
Flamm, RK; Mendes, RE; Sader, HS; Streit, JM1
Cerrone, R; Coviello, T; Devine, D; Di Meo, C; Francioso, A; Mancini, P; Matricardi, P; Meade, J; Montanari, E; Mosca, L; Oates, A1
Balbuena Segura, AI; Corrales Fernández, MJ; Gea Velázquez de Castro, MT1
Amano, A; Ikeda, F; Ishii, R; Kanayama, S; Matsumoto, S; Matsumoto, T; Matsuzaki, K; Nakajima, A; Okamoto, K1
Castanheira, M; Farrell, DJ; Jones, RN; Turner, LL1
Fish, DN1
Amaratunga, D; Barrett, JF; Fernandez, J; Frosco, M; Licata, L1
Hayashi, K; Mitsuyama, J; Yamakawa, T1

Reviews

1 review(s) available for levofloxacin and Staphylococcal Skin Infections

ArticleYear
Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'.
    Expert review of anti-infective therapy, 2003, Volume: 1, Issue:3

    Topics: Animals; Drug Resistance, Microbial; Humans; Levofloxacin; Ofloxacin; Quinolones; Respiratory Tract Infections; Staphylococcal Skin Infections

2003

Other Studies

8 other study(ies) available for levofloxacin and Staphylococcal Skin Infections

ArticleYear
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome

2007
Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clindamycin; Erythromycin; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Skin Infections; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States

2017
Hyaluronan-Based Nanohydrogels for Targeting Intracellular S. Aureus in Human Keratinocytes.
    Advanced healthcare materials, 2018, Volume: 7, Issue:12

    Topics: Drug Delivery Systems; Humans; Hyaluronic Acid; Hydrogels; Keratinocytes; Levofloxacin; Nanostructures; Staphylococcal Skin Infections; Staphylococcus aureus

2018
[Skin infection by community-acquired methicillin resistant Staphylococcus aureus with familial transmission].
    Medicina clinica, 2016, Feb-05, Volume: 146, Issue:3

    Topics: Abscess; Adolescent; Adult; Anti-Bacterial Agents; Carrier State; Child; Community-Acquired Infections; Drug Therapy, Combination; Emergencies; Family Health; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Parents; Siblings; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2016
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:10

    Topics: Administration, Cutaneous; Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Child; Female; Fluoroquinolones; Humans; Japan; Levofloxacin; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolizines; Quinolones; Skin Cream; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Streptococcus pyogenes

2016
Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial.
    Diagnostic microbiology and infectious disease, 2012, Volume: 74, Issue:1

    Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Staphylococcal Skin Infections; Staphylococcus aureus

2012
Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:3

    Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Female; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Staphylococcal Skin Infections

1999
In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:3

    Topics: Animals; Anti-Infective Agents; Clindamycin; Colony Count, Microbial; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gene Frequency; Genes, Bacterial; Gentamicins; Levofloxacin; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation; Ofloxacin; Quinolines; Quinolizines; Staphylococcal Skin Infections; Staphylococcus aureus; Staphylococcus epidermidis; Topoisomerase II Inhibitors

2002